Malignant tumours following immunosuppression in renal transplantation.
D000230:Adenocarcinoma / Q000209:etiology; D000328:Adult; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000209:etiology; D002277:Carcinoma / Q000209:etiology; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D002291:Carcinoma, Papillary / Q000209:etiology; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000209:etiology; D016030:Kidney Transplantation; D008113:Liver Neoplasms / Q000209:etiology; D008175:Lung Neoplasms / Q000209:etiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000209:etiology; D008297:Male; D008545:Melanoma / Q000209:etiology; D008875:Middle Aged; D009369:Neoplasms / Q000209:etiology*; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000209:etiology; D012878:Skin Neoplasms / Q000209:etiology; D014019:Tissue Donors; D014184:Transplantation, Homologous; D001749:Urinary Bladder Neoplasms / Q000209:etiology
D011239:Prednisolone; D001379:Azathioprine